From Indiana University Plans Alumni Venture Fund, Taps Partnerships:

Tony Armstrong—

Tony Armstrong, president and CEO of Indiana University’s Research and Technology Corporation, and assistant vice president in the Office of the Vice President for Engagement.

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Axsome Plans to Try Again After Failure in Treatment-Resistant Depression

A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy

San Diego Biotech Entrepreneurs, Innovation Lead to “Maturing” Ecosystem

With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Rubius Drops Rare Diseases, Turns to Cancer and Autoimmune Disorders

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

Xcelerating Life Sciences Boston

2020 National Xconomy Awards

Xcelerating Life Sciences San Francisco

From Indiana University Plans Alumni Venture Fund, Taps Partnerships:

Underwriters and Partners

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Xconomy on Demand

We offer a number of ways to subscribe for free!